In summary, we demonstrate that UCP2 expression downregulation by high-salt diet associates with increased stroke predisposition whereas UCP2 upregulation, by both nutraceutical and pharmacological agents, associates with a significant stroke protection in high-salt-fed SHRSP. The gene discussed is UCP2; the disease is stroke disorder.